BCAN was founded in 2005 and is the only national advocacy organization devoted to advancing bladder cancer research and supporting those impacted by the disease.
BCAN is on the front-lines advocating for greater public awareness and increased funding for research to identify effective treatments and eventually, a cure for bladder cancer.
Each year, BCAN provides thousands of patients, caregivers and the medical community with the educational resources and support services they need to navigate their bladder cancer journey. BCAN works collaboratively with the medical and research professionals who are dedicated to the prevention, diagnosis and treatment of bladder cancer and empowers the patient community by allowing them to share experiences with others, and to participate in building awareness of the need for a cure.
Watch Dr. Stephanie Chisolm, Director of Education & Research at BCAN provide an overview of the Bladder Cancer Advocacy Network on Cure Connection.
Diane and her husband John Quale, a bladder cancer patient, launch the Bladder Cancer Advocacy Network (BCAN) with the goal of improving the national conversation about bladder cancer and advancing research to find better treatments.
The first Bladder Cancer Think Tank is held in Aspen, Colorado, with 35 medical professionals and survivors attending. Today over 200 urologists, oncologists, pathologists, social scientists, patient advocates and industry partners attend the only annual scientific meeting in North America dedicated to bladder cancer.
First edition of Bladder Cancer Basics for the Newly Diagnosed is printed. Over 250,000 copies have been distributed.
BCAN awards its first research grant.
First national Walk for Bladder Cancer is held in more than 25 communities across the country.
BCAN hosts the first bladder cancer Capitol Hill Day. Advocates from across the country discuss the importance of bladder cancer awareness and increased research funding with their legislators.
Senate Resolution designates May as Bladder Cancer Awareness Month.
BCAN launches the Bladder Cancer Genomics Consortium (BCGC). The BCGC’s ultimate goal is to provide the opportunity for every patient to be an exceptional responder to personalized therapy while advancing collaborative research to support the development of life-saving treatments for bladder cancer.
A bladder cancer diagnosis can be overwhelming and perhaps frightening—not just for the patient but for family and friends as well. There are many resources available for finding support and connecting with others impacted by bladder cancer.
John C. Quale
In June 2008, BCAN lost its co-founder and board member, John Quale, to bladder cancer. His death leaves a hole in our bladder cancer family but his life serves as motivation to continue our important work.
The information contained in this website is for general information purposes only. The information is provided by the Bladder Cancer Advocacy Network and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website, you are able to link to other websites which are not under the control of Bladder Cancer Advocacy Network. We have no control over the nature, content, and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, Bladder Cancer Advocacy Network takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
Your email and/or postal address will not be sold or given to any third parties, nor will BCAN use them for any reason other than to keep you informed about BCAN news and events.
We do not require submission of any personally identifiable information from you to use this web site. However, in order to participate in certain services we offer, we may require you to provide information that personally identifies you. You are, of course, under no obligation to use these services. Such information is generally collected through the “Contact Us” section of the web site or when you donate to BCAN, but it may be collected in other ways as well.
By providing us with your personal information, you consent to us providing such information to (a) third parties that are working with us in connection with the applicable service you have requested or joined and (b) any of our partners listed on our website. We may also provide third parties with aggregated information. This is information about our users in an aggregate form where the identity of individual users cannot be determined. We will not sell, rent or otherwise share your personal information with any other third party unless you provide us with your consent.
We will not provide any third party with any medical information you provide to us. Medical Information includes information about diseases, treatments, and other similar information. We may, however, use this information – with your consent – to match you with a BCAN volunteer with a similar profile if you request that we do so. That individual will not be provided with your medical information but will know that some aspect of your medical information created a match with their own information.